MarketScreener Strategies Vertex Pharmaceuticals Incorporated

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 14/04/2026 BST			Pre-market 13:13:06
444.28 ^USD	+0.96%		439.93	-0.98%

04-10	RBC Trims Price Target on Vertex Pharmaceuticals to $541 From $543, Keeps Outperform Rating	MT
04-09	Evercore ISI Adjusts Vertex Pharmaceuticals PT to $535 From $530, Maintains Outperform Rating	MT

	Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease	December 11, 2023 at 10:47 am
	Vertex Pharmaceuticals Incorporated : Confirms growth trajectory	May 04, 2023 at 02:35 pm
	Vertex Pharmaceuticals : A very promising pipeline	January 11, 2023 at 10:20 am